Assignee
AMPHIVENA THERAPEUTICS INC
US·4 granted patents·4 pending applications·34 citations·filing 2015–2020
Top patents by PatentIndex Score
8 records- 0192US9212225B1Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2015·Granted Dec 15, 2015·17 cites·14 claims
- 0290US9803029B2Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2015·Granted Oct 31, 2017·11 cites·18 claims
- 0388US10626190B2Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2017·Granted Apr 21, 2020·3 cites·12 claims
- 0484US10738118B2Methods of using bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2016·Granted Aug 11, 2020·3 cites·21 claims
- 0565US2021024654A1Bispecific CD33 and CD3 Binding ProteinsAMPHIVENA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0653US2020377596A1Dosing of bispecific t cell engagerAMPHIVENA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0744US2021324076A1Cd33×cd3 binding proteins for treating inflammatory conditions and diseasesAMPHIVENA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0840US2020262920A1Dosing regimen for cd3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AMPHIVENA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →